Guidelines

Challenging the Salt Restriction Norm

It is common practice to restrict dietary salt to alleviate or prevent “volume overload” in patients with acute decompensated heart failure (ADHF). But a new study reveals that this standard may be unnecessary. 

This double-blind randomized controlled trial investigated whether taking salt pills may actually benefit patients with ADHF undergoing intensive diuresis. Turns out, the approach made no difference to weight loss on diuresis (a proxy for volume reduction) or serum creatine levels in ADHF patients receiving high-dose IV diuretic therapy. 

The Cleveland Clinic researchers instructed 65 patients hospitalized with ADHF to take either placebo or 6mg salt per day (approximately equivalent to six servings of fast-food french fries) during diuresis for up to 96 hours. The primary endpoint was change in creatinine and weight at 96 hours.

  • The authors found that change in weight (–4 vs. –4.6 kg) and creatine (0.04 vs. 0.15 mg/dL) was comparable between the salt-ingesters and the placebo group. 
  • The authors also noted a smaller decrease in serum sodium (–0.03 vs. –2.6) and a smaller mean increase in blood urea nitrogen (3.1 vs. 11 mEq/L) in salt-ingesters versus the placebo group.
  • The trial was not powered to detect differences in serious adverse events, but the researchers reported that they observed none.

The Takeaway

These results challenge the routine practice of restricting salt consumption in ADHF cases. Nothing catastrophic happened when patients ingested salt in bulk; weight and creatine levels were similar between the experimental and control groups. 

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Heart Failure October 20, 2025

Don’t Blame Your Heart for Heart Failure October 20, 2025

Perhaps the biggest cardiology story of the year, an entire issue of JACC now hypothesizes that heart failure with preserved ejection fraction (HFpEF) might actually be caused by visceral fat tissue that triggers cardiac weakening through adipokine signaling. The new unifying adiposity framework now proposes that visceral fat expansion causes secretion of an altered adipokine […]

Cardiology Business October 16, 2025

MedAxiom Report: Cardiologist Compensation Soars, Patient Access Struggles October 16, 2025

Good news and bad news from MedAxiom’s latest cardiology compensation survey. The good news? Cardiologist median compensation reached new record highs last year. The bad news? Patient access deteriorated while the number of patients physicians had to manage swelled. The 2025 survey findings aggregated data across cardiology, cardiac surgery, and vascular surgery specialties, examining compensation […]

Heart Failure October 13, 2025

Specialist Care Can Improve HF Outcomes Across the Board October 13, 2025

A recent study out of the U.K. suggests that multidisciplinary team management could significantly reduce death or rehospitalization risk for HF patients across the LVEF spectrum. Based in a single U.K. county, the Buckinghamshire analysis examined 2.1k patients hospitalized for acute heart failure who received either specialist care or standard care over a 618-day follow-up […]